Literature DB >> 6822431

Lipid A in anaerobic bacteria.

G Dahlén, I Mattsby-Baltzer.   

Abstract

The ability of lipid A preparations from strains of Bacteroides, Fusobacterium, and Veillonella to inhibit the lipid A-anti-lipid A reaction in an enzyme-linked immunosorbent assay was tested. Anti-lipid A serum was prepared with lipid A from Salmonella minnesota R595, and lipid A from Escherichia coli EH100 was used as control antigen. Preparations from three of four different species of Bacteroides were unable to inhibit the anti-lipid A activity, whereas lipid A preparations from Fusobacterium and Veillonella strains inhibited 50% of the activity at 1 to 141 micrograms. One of the Bacteroides strains, Bacteroides oralis, showed a very weak inhibiting activity at the highest concentration used. The results confirm that Bacteroides species have a unique lipopolysaccharide structure, in contrast to other anaerobic genera which have a lipopolysaccharide structure similar to that of the Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822431      PMCID: PMC347965          DOI: 10.1128/iai.39.1.466-468.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis.

Authors:  D L Kasper
Journal:  J Infect Dis       Date:  1976-07       Impact factor: 5.226

2.  Biological properties of lipid A from Shigella sonnei.

Authors:  C Lugowski; E Romanowska
Journal:  Eur J Biochem       Date:  1974-10-01

3.  The distribution of heptose and 2-keto-3-deoxy-octonate in Bacteroidaceae.

Authors:  T Hofstad
Journal:  J Gen Microbiol       Date:  1974-12

Review 4.  Taxonomy, enzymes, and clinical relevance of anaerobic bacteria.

Authors:  S M Finegold
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

5.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

6.  Biochemical studies on lipopolysaccharides of Veillonella.

Authors:  D G Bishop; M J Hewett; K W Knox
Journal:  Eur J Biochem       Date:  1971-03-11

7.  Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component.

Authors:  C Galanos
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

8.  Chemical structure of the lipid A component of lipopolysaccharides from Fusobacterium nucleatum.

Authors:  S Hase; T Hofstad; E T Rietschel
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

9.  Endotoxic activities of lipopolysaccharides of microorganisms isolated from an infected root canal in Macaca cynomolgus.

Authors:  G Dahlén; T Hofstad
Journal:  Scand J Dent Res       Date:  1977-05

10.  Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.

Authors:  M A Johns; S C Bruins; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

View more
  5 in total

1.  Monoclonal antibodies against surface antigens of Bacteroides gingivalis.

Authors:  Y Naito; K Okuda; T Kato; I Takazoe
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

2.  Hemagglutinating activity of lipopolysaccharides from subgingival plaque bacteria.

Authors:  K Okuda; T Kato
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Lipid A in Helicobacter pylori.

Authors:  I Mattsby-Baltzer; Z Mielniczuk; L Larsson; K Lindgren; S Goodwin
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

4.  A fluorescent Gram stain for flow cytometry and epifluorescence microscopy.

Authors:  D J Mason; S Shanmuganathan; F C Mortimer; V A Gant
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792

5.  Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.

Authors:  T Kato; I Takazoe; K Okuda
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.